A case of pulmonary sclerosing pneumocytoma diagnosed preoperatively using transbronchial cryobiopsy.

Cryobiopsy Pulmonary sclerosing pneumocytoma

Journal

Respiratory medicine case reports
ISSN: 2213-0071
Titre abrégé: Respir Med Case Rep
Pays: England
ID NLM: 101604463

Informations de publication

Date de publication:
2021
Historique:
received: 27 02 2021
revised: 05 05 2021
accepted: 10 08 2021
entrez: 25 8 2021
pubmed: 26 8 2021
medline: 26 8 2021
Statut: epublish

Résumé

The preoperative diagnosis of pulmonary sclerosing pneumocytoma (PSP) is complicated since PSP has several histological structural patterns in the same neoplasm; hence, it is sometimes pathologically misdiagnosed as adenocarcinoma or carcinoid. In recent years, with the prevalence of transbronchial cryobiopsy (TBLC), we are able to obtain larger specimens than previously. However, to date, there have been no reports describing PSP diagnosed using TBLC. A 43-year-old man was referred to our hospital for an abnormal lesion in the left lung discovered on routine health examination. A computed tomography scan of the chest revealed a 14-mm heterogeneous round nodule with surrounding ground-glass opacity in the left lower lobe. The tumor size increased to 18 mm in three weeks, and he developed bloody sputum. TBLC was performed using radial endobronchial ultrasonography and fluoroscopy. An occlusion balloon and prophylactic epinephrine were used to prevent severe bleeding. Histologically, epithelioid cells with solid proliferation, various papillary lesions, and hemosiderin-laden histiocytes were observed. Immunohistochemical staining revealed the histiocytes positive for thyroid transcription factor-1 and vimentin, and the type II pneumocyte-like-cells positive for cytokeratin 7. The tumor was preoperatively diagnosed as a PSP; the patient underwent left basal segmentectomy and consequently, a final diagnosed of PSP was formulated. We report the first case of PSP preoperatively diagnosed using TBLC. Therefore, cryobiopsy could be beneficial in the preoperative diagnosis of PSP.

Sections du résumé

BACKGROUND BACKGROUND
The preoperative diagnosis of pulmonary sclerosing pneumocytoma (PSP) is complicated since PSP has several histological structural patterns in the same neoplasm; hence, it is sometimes pathologically misdiagnosed as adenocarcinoma or carcinoid. In recent years, with the prevalence of transbronchial cryobiopsy (TBLC), we are able to obtain larger specimens than previously. However, to date, there have been no reports describing PSP diagnosed using TBLC.
CASE REPORTS METHODS
A 43-year-old man was referred to our hospital for an abnormal lesion in the left lung discovered on routine health examination. A computed tomography scan of the chest revealed a 14-mm heterogeneous round nodule with surrounding ground-glass opacity in the left lower lobe. The tumor size increased to 18 mm in three weeks, and he developed bloody sputum. TBLC was performed using radial endobronchial ultrasonography and fluoroscopy. An occlusion balloon and prophylactic epinephrine were used to prevent severe bleeding. Histologically, epithelioid cells with solid proliferation, various papillary lesions, and hemosiderin-laden histiocytes were observed. Immunohistochemical staining revealed the histiocytes positive for thyroid transcription factor-1 and vimentin, and the type II pneumocyte-like-cells positive for cytokeratin 7. The tumor was preoperatively diagnosed as a PSP; the patient underwent left basal segmentectomy and consequently, a final diagnosed of PSP was formulated.
CONCLUSION CONCLUSIONS
We report the first case of PSP preoperatively diagnosed using TBLC. Therefore, cryobiopsy could be beneficial in the preoperative diagnosis of PSP.

Identifiants

pubmed: 34430194
doi: 10.1016/j.rmcr.2021.101494
pii: S2213-0071(21)00156-8
pmc: PMC8365508
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101494

Informations de copyright

© 2021 Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

None.

Références

Medicine (Baltimore). 2015 Jan;94(4):e498
pubmed: 25634202
ERJ Open Res. 2019 Oct 21;5(4):
pubmed: 31649952
Respir Med Case Rep. 2019 Feb 13;26:285-287
pubmed: 30847275
BMC Cancer. 2019 Nov 27;19(1):1154
pubmed: 31775674
Front Med (Lausanne). 2020 Sep 02;7:497
pubmed: 32984377
J Thorac Oncol. 2016 Oct;11(10):1802-4
pubmed: 27346414
Clin Respir J. 2018 Apr;12(4):1711-1720
pubmed: 29105361
Medicine (Baltimore). 2019 Apr;98(15):e15038
pubmed: 30985653
Thorac Cancer. 2019 Jul;10(7):1552-1560
pubmed: 31131992
Thorac Cardiovasc Surg. 2008 Mar;56(2):120-2
pubmed: 18278694
Respir Res. 2019 Jul 5;20(1):140
pubmed: 31277659
Ann Thorac Surg. 1992 Feb;53(2):295-300
pubmed: 1309991
Korean J Intern Med. 2015 Nov;30(6):928-30
pubmed: 26552471
Chin Med J (Engl). 2016 Jun 5;129(11):1377-8
pubmed: 27231179
Oncol Lett. 2018 Jul;16(1):660-665
pubmed: 29930720
Korean J Thorac Cardiovasc Surg. 2011 Feb;44(1):39-43
pubmed: 22263122
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008
Thorax. 2013 Aug;68 Suppl 1:i1-i44
pubmed: 23860341
J Thorac Dis. 2017 Sep;9(9):2974-2981
pubmed: 29221270
Ann Thorac Surg. 2004 Dec;78(6):1928-31
pubmed: 15561002
AJR Am J Roentgenol. 2006 Aug;187(2):430-7
pubmed: 16861548
Histopathology. 2002 Nov;41(5):392-403
pubmed: 12405907
Respirology. 2017 Apr;22(3):443-453
pubmed: 28177181
Surg Today. 2011 Feb;41(2):258-61
pubmed: 21264765
Ann Thorac Med. 2010 Oct;5(4):242-6
pubmed: 20981186
Oncol Lett. 2014 Apr;7(4):997-1000
pubmed: 24944657
Am J Surg Pathol. 1980 Aug;4(4):343-56
pubmed: 6252791
Histopathology. 2018 Feb;72(3):500-508
pubmed: 28881050
Respiration. 2014;88(5):430-40
pubmed: 25402610
Surg Today. 1997;27(4):310-2
pubmed: 9086546
Chest. 2013 May;143(5 Suppl):e142S-e165S
pubmed: 23649436
Ann Thorac Cardiovasc Surg. 2014;20(1):19-25
pubmed: 24807472

Auteurs

Yutaka Muto (Y)

Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Naoyuki Kuse (N)

Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Minoru Inomata (M)

Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Nobuyasu Awano (N)

Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Mari Tone (M)

Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Jonsu Minami (J)

Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Kohei Takada (K)

Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Kazushi Fujimoto (K)

Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Ami Wada (A)

Department of Thoracic Surgery, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Keita Nakao (K)

Department of Thoracic Surgery, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Yoshiaki Furuhata (Y)

Department of Thoracic Surgery, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Chisa Hori (C)

Department of Pathology, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Yuan Bae (Y)

Department of Pathology, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Toshio Kumasaka (T)

Department of Pathology, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Takehiro Izumo (T)

Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8953, Japan.

Classifications MeSH